InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Karlin Daniel. Director active across 2 companies, notably Mind Medicine (MindMed) Inc.. In total, 10 filings have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €343k. Activity tracked since 12 March 2025. The latest transaction was filed on 12 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Karlin Daniel is a declarant linked to Mind Medicine (MindMed) Inc. and Definium Therapeutics, Inc., where he is Chief Medical Officer. Across 9 filings in total, the 9 sampled filings, from 2025-03-13 to 2026-06-26, are sales for a total of EUR 342835, including sales published on 2026-03-26 at Definium Therapeutics, Inc. and on 2025-09-26, 2025-12-29, 2025-06-26, and 2025-03-26 at Mind Medicine (MindMed) Inc.